Publication | Closed Access

Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection

HepatologyMedicineRecurrence-after ResectionHepatobiliary TumorImmunologyNeoadjuvant TreatmentLiver CancerImmunotherapyOncologyRadiation OncologyParent TumorCancer ResearchViral Oncology